Methadone Hydrochloride

Opioid Analgesic Synthetic Opioid (Phenylheptylamine derivative) Rx Controlled Schedule II (US); Controlled Drug (UK Schedule 2)

Dosage & Administration Guidelines

Species Route Dose Frequency Duration & Clinical Notes
Dog IV, IM, SC 0.1-0.5 mg/kg (up to 1 mg/kg in some cases) q4-6h (IV/IM); q6-12h (oral) Duration: As needed for pain; for chronic pain, titrate to effect
Notes: Lower doses for premedication; higher doses for severe pain. Monitor respiratory rate.
Cat IV, IM, SC 0.1-0.5 mg/kg (up to 0.6 mg/kg) q4-6h (IV/IM); q6-12h (oral) Duration: As needed for pain; for chronic pain, titrate to effect
Notes: Cats may exhibit excitation at high doses; use lower end for premedication.
Horse IV, IM 0.05-0.1 mg/kg (IV); 0.1-0.2 mg/kg (IM) q4-6h Duration: As needed for pain
Notes: Use cautiously in horses with respiratory disease; may cause ileus.
Rabbit SC, IM, IV 0.5-1.0 mg/kg q4-6h Duration: As needed for pain
Notes: Limited data; use with caution and monitor for respiratory depression.
Bird (companion) IM 0.5-1.0 mg/kg q4-6h Duration: As needed for pain
Notes: Limited data; use with caution.

Clinical Indications & Species Uses

General Indications
  • Moderate to severe pain management
  • Anesthetic premedication
  • Neuropathic pain (adjunct)
Dog (Canine)
  • Management of moderate to severe pain
  • Preoperative analgesia
  • Postoperative analgesia
  • Chronic pain management (adjunct)
  • Cough suppression (off-label)
Cat (Feline)
  • Management of moderate to severe pain
  • Preoperative analgesia
  • Postoperative analgesia
  • Chronic pain management (adjunct)
Horse (Equine)
  • Management of moderate to severe pain
  • Preoperative analgesia
  • Postoperative analgesia
  • Colic pain (off-label)
Cattle (Bovine)
  • Analgesia in non-food animals (off-label)
Small Ruminants (Sheep / Goat)
  • Analgesia in non-food animals (off-label)
Rabbit & Small Mammals
  • Analgesia (off-label)
  • Preoperative and postoperative pain management
Avian & Poultry
  • Analgesia (off-label)
Exotic & Other Species
  • Analgesia in small mammals (off-label)
  • Analgesia in reptiles (off-label)

Pharmacology & Mechanism of Action

Drug Class: Opioid Analgesic | Pharmacological Group: Synthetic Opioid (Phenylheptylamine derivative)

Mechanism of Action: Methadone is a synthetic opioid that acts primarily as a mu-opioid receptor agonist. It produces analgesia by binding to mu receptors in the central nervous system, leading to activation of descending inhibitory pain pathways, inhibition of neurotransmitter release (e.g., substance P), and modulation of pain perception. Additionally, methadone has N-methyl-D-aspartate (NMDA) receptor antagonist properties, which may contribute to its efficacy in neuropathic pain and its ability to reduce opioid tolerance. It also inhibits the reuptake of serotonin and norepinephrine, further enhancing analgesic effects.

Pharmacodynamics: Methadone produces dose-dependent analgesia, sedation, and respiratory depression. Its analgesic potency is roughly equivalent to morphine, but it has a longer duration of action due to its long half-life. Methadone also has antitussive effects and can cause miosis, bradycardia, and hypothermia. In veterinary patients, it may cause less histamine release compared to morphine, resulting in fewer cardiovascular and dermatologic side effects. Its NMDA antagonism may provide additional benefits in chronic pain states.

⚡ Pharmacokinetics Summary

Absorption: Methadone is well absorbed after oral, subcutaneous, and intramuscular administration. Oral bioavailability is variable (approximately 40-80% in dogs) due to first-pass metabolism. In horses, oral bioavailability is low (around 20-30%).
Distribution: Methadone is highly lipophilic and distributes widely into tissues, including the brain, lungs, liver, and kidneys. It crosses the placenta and is secreted in milk. Volume of distribution is large (approximately 4-7 L/kg in dogs).
Metabolism: Methadone undergoes extensive hepatic metabolism primarily via N-demethylation to inactive metabolites (2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine, EDDP). The cytochrome P450 enzymes involved include CYP3A4, CYP2B6, and CYP2D6 in humans; similar pathways are presumed in animals. In dogs, metabolism is slower than in humans, leading to a longer half-life.
Excretion: Methadone and its metabolites are excreted primarily in urine (as unchanged drug and metabolites) and to a lesser extent in feces via biliary excretion. Renal excretion is pH-dependent; acidic urine increases elimination.
Half-Life: Dog: 10-20 hours; Cat: 6-12 hours; Horse: 2-4 hours; Human: 24-36 hours.
Bioavailability: Oral: Dogs 40-80%, Cats 50-90%, Horses 20-30%; IM/SC: nearly 100% in dogs and cats.
Protein Binding: Methadone is approximately 85-90% bound to plasma proteins, primarily alpha-1-acid glycoprotein.

Available Formulations & Strengths

Injectable Solution 10 mg/mL (IV, IM, SC)
Oral Tablet 5 mg, 10 mg (PO)
Oral Solution 1 mg/mL, 5 mg/mL, 10 mg/mL (PO)

Contraindications & Clinical Warnings

Contraindications:
  • Hypersensitivity to methadone or other opioids
  • Severe respiratory depression
  • Acute asthma or severe chronic obstructive pulmonary disease
  • Gastrointestinal obstruction or ileus
  • Concurrent use of monoamine oxidase inhibitors (MAOIs) or within 14 days
  • Use in animals with head trauma or increased intracranial pressure (unless ventilated)
  • Use in animals with hepatic or renal insufficiency (use with caution)
Warnings & Clinical Precautions:
  • Use with caution in animals with respiratory compromise, bradycardia, hypotension, or hypovolemia
  • May cause sedation and CNS depression; monitor for excessive sedation
  • May cause constipation and urinary retention; monitor gastrointestinal function
  • In cats, high doses may cause excitement or mania
  • In horses, may cause ileus and colic; use with caution
  • Tolerance and dependence may develop with prolonged use
  • Use with caution in debilitated, geriatric, or very young animals
  • Avoid rapid IV administration to reduce risk of histamine release and hypotension
  • Methadone may prolong QT interval; use with caution in animals with cardiac disease or those receiving other QT-prolonging drugs

Adverse Effects & Reactions

Common:

  • Sedation
  • Respiratory depression
  • Miosis
  • Bradycardia
  • Hypothermia
  • Constipation
  • Urinary retention
  • Vomiting (especially in cats)
  • Dysphoria or excitement (cats)

Serious / Severe:

  • Severe respiratory depression
  • Cardiac arrhythmias (QT prolongation, torsades de pointes)
  • Hypotension
  • Seizures (rare)
  • Ileus (horses)
  • Anaphylactoid reactions

Rare:

  • Allergic reactions
  • Hepatic dysfunction
  • Pancreatitis
  • Serotonin syndrome (when combined with serotonergic drugs)

Key Drug Interactions

Interacting Drug / Class Clinical Effect & Mechanism Severity
Other CNS depressants (barbiturates, benzodiazepines, phenothiazines, anesthetics) Additive CNS and respiratory depression High
Monoamine oxidase inhibitors (MAOIs) Severe respiratory depression, hypotension, coma (avoid concurrent use) High
Serotonergic drugs (SSRIs, SNRIs, TCAs) Increased risk of serotonin syndrome Moderate
QT-prolonging drugs (e.g., fluoroquinolones, macrolides, antifungals) Additive QT prolongation, risk of arrhythmias Moderate
CYP3A4 inhibitors (e.g., ketoconazole, erythromycin) Increased methadone plasma levels, risk of toxicity Moderate
CYP3A4 inducers (e.g., phenobarbital, rifampin) Decreased methadone plasma levels, reduced efficacy Moderate
Anticholinergic drugs Additive anticholinergic effects (constipation, urinary retention) Mild

Overdose & Toxicity Management

Signs of Toxicity:

  • Severe respiratory depression
  • Coma
  • Miosis (or mydriasis in some species)
  • Bradycardia
  • Hypotension
  • Hypothermia
  • Muscle rigidity
  • Seizures (rare)
  • Pulmonary edema

Emergency Treatment Protocol: Maintain airway and provide respiratory support (intubation and mechanical ventilation if needed). Administer naloxone (opioid antagonist) at 0.01-0.04 mg/kg IV, IM, or SC; may need repeated doses or continuous infusion due to methadone's long half-life. Monitor for withdrawal signs (excitement, tachycardia, hypertension) and treat symptomatically. Provide supportive care: fluids, temperature regulation, and cardiac monitoring. In severe cases, consider activated charcoal if oral ingestion within 1-2 hours.

Food Animal Withdrawal Times

Methadone is not approved for use in food-producing animals in most countries. Extra-label use in food animals is prohibited or requires extended withdrawal periods; consult regulatory authorities. In the US, methadone is not permitted in food animals due to lack of residue data.

Storage, Handling & Regulatory Information

Storage Temperature: Store at controlled room temperature (20-25°C, excursions permitted to 15-30°C). Protect from light.

Light Sensitivity: Light-sensitive — protect from direct exposure.

Handling & Special Conditions: Store in a tightly closed container. Keep out of reach of children and animals. Dispose of unused product properly.

Dispensing Status: Prescription Required (Rx Only)

Approval Status: Approved for use in dogs and cats (injectable solution) in the US. Oral formulations are not FDA-approved for veterinary use but may be used extra-label.

Extra-Label (Off-Label) Use: In the US, methadone is a Schedule II controlled substance and is approved for use in dogs and cats (injectable). Extra-label use in other species is permitted under AMDUCA for non-food animals, but prohibited in food animals. In the EU, methadone is available for dogs and cats; use in food animals is not allowed. Always follow local regulations.

Clinical Pearls & Practice Notes

💡 Clinical Insights: Methadone is a valuable opioid analgesic for moderate to severe pain in small animals. Its long duration of action and NMDA antagonism make it useful for chronic and neuropathic pain. It is often used as a premedication before anesthesia to provide analgesia and reduce anesthetic requirements. Compared to morphine, methadone causes less histamine release, making it safer in patients with cardiovascular compromise. However, its long half-life requires careful dosing and monitoring, especially in patients with hepatic or renal impairment. In cats, lower doses are recommended to avoid excitation. In horses, methadone should be used cautiously due to the risk of ileus. Always monitor respiratory rate and depth, and have naloxone available. Methadone is a controlled substance; proper record-keeping and security are required.

References & Literature

  • 📚 Plumb's Veterinary Drug Handbook
  • 📚 Papich Veterinary Pharmacology and Therapeutics
  • 📚 Compendium of Veterinary Products (CVP)